Capvaxive pneumococcal 21-valent conjugate vaccine 0.5 mL Images
Generic Name: pneumococcal 21-valent conjugate vaccine
This medication has been identified as Capvaxive pneumococcal 21-valent conjugate vaccine 0.5 mL. It is supplied by Merck.
Capvaxive is used in the treatment of Pneumococcal Disease Prophylaxis and belongs to the drug class bacterial vaccines. Capvaxive pneumococcal 21-valent conjugate vaccine 0.5 mL is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Capvaxive
- Generic Name
- pneumococcal 21-valent conjugate vaccine
- Strength
- pneumococcal 21-valent conjugate vaccine 0.5 mL
- Availability
- Prescription only
- Drug Class
- Bacterial vaccines
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck
- National Drug Code (NDC)
- 00006-4347
See also:
Prevnar 20
Prevnar 20 is used to prevent pneumococcal disease, a serious infection caused by pneumococcal ...
Pneumovax 23
Pneumovax 23 information from Drugs.com, includes Pneumovax 23 side effects, interactions and ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Vaxneuvance
Vaxneuvance (pneumococcal 15-valent conjugate vaccine) is a vaccine used for the prevention of ...
More about Capvaxive (pneumococcal 21-valent conjugate vaccine)
- Check interactions
- Compare alternatives
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bacterial vaccines
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.